Evolution of the Average Target: UGI Corporation

Evolution of the Target Price: UGI Corporation

Changes in Analyst Recommendations: UGI Corporation

b3b13abb3128e26771.EYLepXEyVby71xAb55emGOjwTgTZRz8u1rjgU569-8o.Z9aHnBNZE4XNtXNTqvOLX6upGEGqGAtkjsiaZcvtyrlS2LTLFXkY5tDhYw~d39c2fc11f72e21d31426a9aab3845f0
15/11/24 Mizuho Upgrades UGI to Outperform From Neutral, Adjusts Price Target to $30 From $27 MT
17/04/24 Mizuho Raises Price Target on UGI to $27 From $26, Keeps Neutral Rating MT
14/03/24 Wells Fargo Downgrades UGI to Equalweight From Overweight, Adjusts Price Target to $28 From $27 MT
18/01/24 Mizuho Adjusts UGI's Price Target to $26 From $29, Keeps Neutral Rating MT
11/09/23 Mizuho Securities Adjusts UGI Price Target to $29 From $33, Maintains Neutral Rating MT
28/08/23 Wells Fargo Upgrades UGI to Overweight From Equalweight, Trims Price Target to $27 From $28 MT
04/08/23 Wells Fargo Adjusts Price Target on UGI to $28 From $35, Maintains Equal-Weight Rating MT
18/04/23 Barclays Adjusts Price Target on UGI to $37 From $40, Maintains Underweight Rating MT
02/02/23 Barclays Adjusts Price Target on UGI to $40 From $39, Maintains Underweight Rating MT
18/01/23 Barclays Downgrades UGI to Underweight From Equalweight, Price Target is $39 MT
18/01/23 Analyst recommendations: Adobe, AstraZeneca, Morgan Stanley, Oracle... Zonebourse
10/01/23 Wells Fargo Adjusts Price Target on UGI to $42 From $41, Maintains Equal-Weight Rating MT
23/11/22 BofA Securities Downgrades UGI to Underperform From Neutral, Adjusts Price Target to $41 From $43 MT
21/11/22 Wells Fargo Adjusts Price Target on UGI to $39 From $36, Maintains Equal-Weight Rating MT
19/10/22 Barclays Trims UGI's Price Target to $36 From $40, Maintains Equalweight Rating MT
19/10/22 Wells Fargo Adjusts UGI's Price Target to $36 From $42, Reiterates Equalweight Rating MT
19/10/22 Barclays Adjusts UGI's Price Target to $36 From $40, Keeps Equalweight Rating MT
08/08/22 Wells Fargo Raises UGI's Price Target to $42 From $41, Maintains Equalweight Rating MT
29/04/22 Wells Fargo Adjusts UGI's Price Target to $40 from $46, Keeps Equalweight Rating MT
27/04/22 Janney Lowers Fair Value on UGI to $60 From $64, Maintains Buy Rating MT
22/03/22 Barclays Adjusts UGI's Price Target to $40 From $45, Keeps Equalweight Rating MT
07/03/22 BofA Securities Downgrades UGI to Neutral from Buy, Adjusts Price Target to $38 from $46 MT
20/10/21 UGI : Wells Fargo Starts UGI Corp at Equalweight With $46 Price Target MT
06/08/21 UGI : Janney Adjusts Fair Value on UGI to $64 From $61, Maintains Buy Rating MT
24/06/21 Analyst recommendations: Beazley, BP, BWX Technologies, Cineworld, Nutanix... Zonebourse

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+23.25%
+4.15%
+50.48%
+11.45%
+6.07%
+15.87%
- - +18.99%
+55.87%
Average +23.27%
Weighted average by Cap. +20.45%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
35.43USD
Average target price
43.33USD
Spread / Average Target
+22.31%
High Price Target
46.00USD
Spread / Highest target
+29.83%
Low Price Target
40.00USD
Spread / Lowest Target
+12.90%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Mizuho Securities
Wells Fargo Securities
Barclays
BofA Securities
Janney Capital
UBS
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
35.43USD
Average target price
43.33USD
Spread / Average Target
+22.31%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. UGI Stock
  4. Consensus UGI Corporation